EPHB6 and non-small cell lung carcinoma: In NSCLC, another poor prognosis factor has been found to be the downregulation of Ephrin type-B receptor 6 (EPHB6) [48]; a Receptor tyrosine kinase (RTK), the loss of which promotes metastasis.